PubHawk
Gastroenterology September 2025 PMID 40209809

Therapeutic Targeting of Oncogene-Induced Transcription-Replication Conflicts in Pancreatic Ductal Adenocarcinoma.

Shanna J Smith, Fan Meng, Robert G Lingeman, Caroline M Li, Min Li, Galyah Boneh, Toni T Seppälä, Thuy Phan, Haiqing Li, Richard A Burkhart, Vishwas Parekh, Syed Rahmanuddin, Laleh G Melstrom, Robert J Hickey, Vincent Chung

Full text PDF Download social card

Mentions

37
Peak: 8 in Apr 2025
across 6 sources since Oct 2023

Extended reach

18,946
potential audience

Total likes

11

Video views

566

Mentions per month

Oct 2023 – Apr 2025

Where it's discussed

  • News23 articles
  • YouTube7 videos
  • X / Twitter2 posts
  • Facebook2 posts
  • Blogs2 articles
  • Bluesky1 posts

AI synopsis

What people are saying

The discussions demonstrate a balanced appreciation for the study's findings, with comments praising the therapeutic possibilities of AOH1996 and referencing clinical cases, such as tumor shrinkage in early patients. The tone reflects cautious optimism and curiosity about future applications, using words like 'promising' and 'potential' to underscore the perceived significance.

AgreementModerate agreement

Most discussions acknowledge the significance and potential of the study, with some emphasizing the promising clinical implications.

InterestModerate interest

Participants show moderate interest by engaging with the research details and potential treatments, though some focus on specific cases or limitations.

EngagementModerate engagement

Comments often reference methodology and clinical trials, indicating a thoughtful and reflective engagement.

ImpactModerate impact

There is a shared view that this research could have important ramifications for pancreatic cancer treatment, suggesting a notable perceived impact.

Abstract in brief

  • The study focuses on targeting transcription-replication conflicts (TRCs), which cause replication stress in pancreatic ductal adenocarcinoma (PDAC), with the molecule AOH1996 showing promising preclinical and initial clinical activity.
  • AOH1996 works by disrupting replication forks and increasing TRCs, especially in cancers dependent on the KRASG12D oncogene, leading to DNA damage, cell death, and reduced tumor growth in models without significant toxicity.
  • Early clinical evidence from two PDAC patients indicates that AOH1996 can shrink tumors, suggesting it may be an effective treatment for chemotherapy-resistant PDAC, warranting further clinical trials.
Read the full abstract

Top posts

Most liked on X and Bluesky
medRxiv
@medrxivpreprint · X

Therapeutic Targeting of Oncogene-induced Transcription-Replication Conflicts in Pancreatic Ductal Adenocarcinoma https://t.co/Gi4OQM8zGv #medRxiv

Oct 6, 2023 · 17,460 followers View post →
サイエンスあれこれ
@sarekore · X

ことがわかりました。次に、膵臓腫瘍が以前の治療に抵抗性を示した2人の患者（NCT05227326）にこの治療法をテストしたところ、患者は2か月間、1日2回の錠剤を服用した結果、肝臓転移が最大49％縮小しました。https://t.co/Bnu6raIMpc

Apr 9, 2025 · 922 followers View post →

All mentions

サイエンスあれこれ
@sarekore · X

ことがわかりました。次に、膵臓腫瘍が以前の治療に抵抗性を示した2人の患者（NCT05227326）にこの治療法をテストしたところ、患者は2か月間、1日2回の錠剤を服用した結果、肝臓転移が最大49％縮小しました。https://t.co/Bnu6raIMpc

Apr 9, 2025 · 922 followers View post →
medRxivpreprint
@medrxivpreprint.bsky.social · Bluesky

Therapeutic Targeting of Oncogene-induced Transcription-Replication Conflicts in Pancreatic Ductal Adenocarcinoma https://www.medrxiv.org/content/10.1101/2023.10.03.23296487v1

Oct 6, 2023 View post →
medRxiv
@medrxivpreprint · X

Therapeutic Targeting of Oncogene-induced Transcription-Replication Conflicts in Pancreatic Ductal Adenocarcinoma https://t.co/Gi4OQM8zGv #medRxiv

Oct 6, 2023 · 17,460 followers View post →